Dr. Chandra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
320 Lennon Ln
Walnut Creek, CA 94598Phone+1 925-906-2010
Education & Training
- University of FloridaResidency, Ophthalmology, 1997 - 2000
- Santa Barbara Cottage HospitalInternship, Internal Medicine, 1996 - 1997
- University of Michigan Medical SchoolClass of 1996
- Northwestern UniversityBA, With Distinction & Honors In Biology, 1992
Certifications & Licensure
- CA State Medical License 2000 - 2026
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Resident of the Year Department of Ophthalmology, University of Florida, 1999
- VAMC Compassion and Courtesy Award 1999
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsTriamcinolone Acetonide Subconjunctival Injection as Stand-alone Inflammation Prophylaxis after Phacoemulsification Cataract Surgery.Neal H Shorstein, Shannon E McCabe, Mubarika Alavi, Marilyn L Kwan, Naveen S Chandra
Ophthalmology. 2024-10-01 - 3 citationsThe Safety Profile of FDA-Approved Epithelium-Off Corneal Cross-Linking in a US Community-Based Healthcare System.Michael J Ang, Jeanne A Darbinian, Eliza N Hoskins, Douglas S Holsclaw, Sudha Sudesh
Clinical Ophthalmology. 2022-01-01 - Where to inject the triamcinoloneNeal H. Shorstein, Naveen S Chandra, Ethan M Kutzscher
Journal of Cataract and Refractive Surgery. 2018-03-01
Journal Articles
- Triamcinolone Acetonide Subconjunctival Injection as Stand-alone Inflammation Prophylaxis after Phacoemulsification Cataract SurgeryNeal H Shorstein 1 , Shannon E McCabe 2 , Mubarika Alavi 3 , Marilyn L Kwan 3 , Naveen S Chandra 4, Ophthalmology, 4/4/2024
- Use of Autologous Serum Eyedrops for the Treatment Of Ocular Surface Disease: First US Experience in a Large Population as an Insurance-Covered BenefitCA Dalmon, NS Chandra, BH Jeng, Arch Ophthalmol, 1/1/2012
- Ocular findings as a presenting sign of hydroavacciniformeBH Jeng, NS Chandra, T McCalmont, TP Margolis, British J of Ophthal, 1/1/2004
- Join now to see all
Authored Content
- Triamcinolone Acetonide Subconjunctival Injection as Stand-alone Inflammation Prophylaxis after Phacoemulsification Cataract SurgeryApril 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: